Last reviewed · How we verify

NCT04645134: BrainFit

Physical Activity and Cognitive Function in Older Adults: A Novel Role for GPLD1

Completed Last updated 16 November 2022
What this trial tests

trial testing Brain Health Assessments in Aging in 25 participants. Completed in 17 March 2022.

Timeline
1 April 2021
Primary endpoint
17 March 2022
17 March 2022

Quick facts

Lead sponsorPennington Biomedical Research Center
StatusCompleted
Study typeOBSERVATIONAL
Enrollment25
Start date1 April 2021
Primary completion17 March 2022
Estimated completion17 March 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Pennington Biomedical Research Center — full company profile →

Who can join

Adults 65 to 85, any sex, with Aging or Cognitive Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators are conducting a cross-sectional, observational study to investigate whether plasma GPLD1 concentrations are associated with higher cognitive function and better brain structure and function in two groups of older adults with high or low levels of physical activity.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Associations between physical activity, brain health, cognitive function, and circulating GPLD1 in healthy older (65-85 years) individuals.
    Marlatt KL, Lowe AC, Sanchez-Delgado G, Beyl RA, et al · · 2025 · cited 2× · PMID 39762691 · DOI 10.1007/s11357-024-01459-8

Verify or expand the search:

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Pennington Biomedical Research Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04645134.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing